HK Stock MarketDetailed Quotes

06955 BOAN BIOTECH

Watchlist
  • 7.780
  • +0.020+0.26%
Market Closed Nov 29 16:08 CST
4.17BMarket Cap61.75P/E (TTM)

BOAN BIOTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
Turnover
38.93%362.94M
19.80%618.13M
18.37%261.23M
225.11%515.96M
1,724.79%220.69M
--158.7M
--12.09M
----
Operating income
38.93%362.94M
19.80%618.13M
18.37%261.23M
225.11%515.96M
1,724.79%220.69M
158.7M
12.09M
Cost of sales
22.04%-80.31M
-29.33%-209.16M
-40.31%-103.02M
-209.89%-161.73M
-2,117.49%-73.42M
---52.19M
---3.31M
----
Operating expenses
22.04%-80.31M
-29.33%-209.16M
-40.31%-103.02M
-209.89%-161.73M
-2,117.49%-73.42M
-52.19M
-3.31M
Gross profit
78.63%282.63M
15.45%408.97M
7.43%158.22M
232.57%354.23M
1,576.75%147.27M
106.51M
8.78M
Selling expenses
-14.61%-134.24M
-19.83%-256.53M
-16.16%-117.12M
-296.10%-214.09M
-1,616.50%-100.83M
---54.05M
---5.87M
----
Administrative expenses
8.45%-24.31M
37.22%-51.69M
29.31%-26.55M
-95.27%-82.33M
-106.16%-37.56M
-844.56%-42.17M
---18.22M
---4.46M
Research and development expenses
31.92%-85.8M
42.38%-230.68M
25.45%-126.03M
-72.88%-400.34M
-51.54%-169.06M
2.01%-231.57M
---111.56M
---236.32M
Special items of operating profit
2,444.23%35.98M
1.89%24.64M
-111.37%-1.54M
224.73%24.19M
198.98%13.51M
-38.25%7.45M
--4.52M
--12.06M
Operating profit
165.71%74.27M
66.93%-105.29M
22.94%-113.02M
-48.88%-318.34M
-19.88%-146.67M
6.51%-213.82M
-122.35M
-228.72M
Financing cost
-101.37%-12.6M
-5.07%-14.09M
5.54%-6.26M
-15.59%-13.41M
-18.78%-6.62M
1.86%-11.6M
---5.58M
---11.82M
Earning before tax
151.71%61.67M
64.02%-119.38M
22.19%-119.27M
-47.17%-331.75M
-19.83%-153.3M
6.29%-225.42M
-127.93M
-240.54M
Tax
----
----
---239K
----
----
----
----
----
After-tax profit from continuing operations
151.60%61.67M
64.02%-119.38M
22.04%-119.51M
-47.17%-331.75M
-19.83%-153.3M
6.29%-225.42M
-127.93M
-240.54M
Earning after tax
151.60%61.67M
64.02%-119.38M
22.04%-119.51M
-47.17%-331.75M
-19.83%-153.3M
6.29%-225.42M
-127.93M
-240.54M
Profit attributable to shareholders
151.60%61.67M
64.02%-119.38M
22.04%-119.51M
-47.17%-331.75M
-19.83%-153.3M
6.29%-225.42M
-127.93M
-240.54M
Basic earnings per share
152.17%0.12
65.67%-0.23
25.81%-0.23
-42.55%-0.67
-10.71%-0.31
92.33%-0.47
-0.28
-6.13
Diluted earnings per share
152.17%0.12
65.67%-0.23
25.81%-0.23
-42.55%-0.67
-10.71%-0.31
92.33%-0.47
-0.28
-6.13
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020
Turnover 38.93%362.94M19.80%618.13M18.37%261.23M225.11%515.96M1,724.79%220.69M--158.7M--12.09M----
Operating income 38.93%362.94M19.80%618.13M18.37%261.23M225.11%515.96M1,724.79%220.69M158.7M12.09M
Cost of sales 22.04%-80.31M-29.33%-209.16M-40.31%-103.02M-209.89%-161.73M-2,117.49%-73.42M---52.19M---3.31M----
Operating expenses 22.04%-80.31M-29.33%-209.16M-40.31%-103.02M-209.89%-161.73M-2,117.49%-73.42M-52.19M-3.31M
Gross profit 78.63%282.63M15.45%408.97M7.43%158.22M232.57%354.23M1,576.75%147.27M106.51M8.78M
Selling expenses -14.61%-134.24M-19.83%-256.53M-16.16%-117.12M-296.10%-214.09M-1,616.50%-100.83M---54.05M---5.87M----
Administrative expenses 8.45%-24.31M37.22%-51.69M29.31%-26.55M-95.27%-82.33M-106.16%-37.56M-844.56%-42.17M---18.22M---4.46M
Research and development expenses 31.92%-85.8M42.38%-230.68M25.45%-126.03M-72.88%-400.34M-51.54%-169.06M2.01%-231.57M---111.56M---236.32M
Special items of operating profit 2,444.23%35.98M1.89%24.64M-111.37%-1.54M224.73%24.19M198.98%13.51M-38.25%7.45M--4.52M--12.06M
Operating profit 165.71%74.27M66.93%-105.29M22.94%-113.02M-48.88%-318.34M-19.88%-146.67M6.51%-213.82M-122.35M-228.72M
Financing cost -101.37%-12.6M-5.07%-14.09M5.54%-6.26M-15.59%-13.41M-18.78%-6.62M1.86%-11.6M---5.58M---11.82M
Earning before tax 151.71%61.67M64.02%-119.38M22.19%-119.27M-47.17%-331.75M-19.83%-153.3M6.29%-225.42M-127.93M-240.54M
Tax -----------239K--------------------
After-tax profit from continuing operations 151.60%61.67M64.02%-119.38M22.04%-119.51M-47.17%-331.75M-19.83%-153.3M6.29%-225.42M-127.93M-240.54M
Earning after tax 151.60%61.67M64.02%-119.38M22.04%-119.51M-47.17%-331.75M-19.83%-153.3M6.29%-225.42M-127.93M-240.54M
Profit attributable to shareholders 151.60%61.67M64.02%-119.38M22.04%-119.51M-47.17%-331.75M-19.83%-153.3M6.29%-225.42M-127.93M-240.54M
Basic earnings per share 152.17%0.1265.67%-0.2325.81%-0.23-42.55%-0.67-10.71%-0.3192.33%-0.47-0.28-6.13
Diluted earnings per share 152.17%0.1265.67%-0.2325.81%-0.23-42.55%-0.67-10.71%-0.3192.33%-0.47-0.28-6.13
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data